Frank Takkinen
Stock Analyst at Lake Street
(1.10)
# 3,802
Out of 5,017 analysts
62
Total ratings
31.58%
Success rate
-11.3%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELUT Elutia | Maintains: Buy | $8 → $6 | $0.90 | +563.06% | 4 | Sep 10, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.5 → $2 | $2.01 | -0.50% | 2 | Aug 14, 2025 | |
| SGHT Sight Sciences | Upgrades: Buy | $3 → $5 | $3.26 | +53.37% | 5 | Aug 8, 2025 | |
| INSP Inspire Medical Systems | Maintains: Buy | $270 → $150 | $77.68 | +93.10% | 2 | Aug 5, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $12 → $8 | $1.59 | +403.14% | 2 | Jul 31, 2025 | |
| ANGO AngioDynamics | Initiates: Buy | $24 | $11.13 | +115.63% | 1 | Jul 16, 2025 | |
| BBNX Beta Bionics | Assumes: Buy | $30 | $22.15 | +35.44% | 1 | Jun 12, 2025 | |
| NOTV Inotiv | Maintains: Buy | $6 → $5 | $1.37 | +264.96% | 7 | May 8, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $19 → $14 | $9.09 | +54.02% | 7 | Apr 8, 2025 | |
| LNSR LENSAR | Downgrades: Hold | $16 → $15 | $11.97 | +25.31% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $15.59 | +92.43% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $19.56 | +32.92% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $26.27 | +14.20% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $4.07 | +22.85% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.45 | +349.44% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.42 | +106.61% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.50 | +433.33% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $40.63 | -26.16% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.90 | +567.85% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $3.07 | +30.29% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $10.48 | +14.50% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $3.00 | +200.00% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $2.09 | +665.55% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.56 | +1,561.87% | 2 | Jan 18, 2023 |
Elutia
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $0.90
Upside: +563.06%
Hyperfine
Aug 14, 2025
Maintains: Buy
Price Target: $1.5 → $2
Current: $2.01
Upside: -0.50%
Sight Sciences
Aug 8, 2025
Upgrades: Buy
Price Target: $3 → $5
Current: $3.26
Upside: +53.37%
Inspire Medical Systems
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $77.68
Upside: +93.10%
Pulmonx
Jul 31, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $1.59
Upside: +403.14%
AngioDynamics
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $11.13
Upside: +115.63%
Beta Bionics
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $22.15
Upside: +35.44%
Inotiv
May 8, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $1.37
Upside: +264.96%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $9.09
Upside: +54.02%
LENSAR
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $11.97
Upside: +25.31%
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $15.59
Upside: +92.43%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $19.56
Upside: +32.92%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $26.27
Upside: +14.20%
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $4.07
Upside: +22.85%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $4.45
Upside: +349.44%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.42
Upside: +106.61%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $1.50
Upside: +433.33%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $40.63
Upside: -26.16%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.90
Upside: +567.85%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $3.07
Upside: +30.29%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $10.48
Upside: +14.50%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.00
Upside: +200.00%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $2.09
Upside: +665.55%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.56
Upside: +1,561.87%